60) Host immune response in the tumor microenvironment plays key roles in |
61) ptide sequence for binding to the bladder tumor microenvironment prior to the initia |
62) epigenetic mechanism by which the hypoxic tumor microenvironment promotes CRC metast |
63) er cells can develop an immunosuppressive tumor microenvironment to control tumor-in |
64) he polyamine metabolism in the pancreatic tumor microenvironment. |
65) the development of the immunosuppressive tumor microenvironment. |
66) in vitro mechanistic studies to mimic the tumor microenvironment. |
67) th a tumor-specific marker and CD4 in the tumor microenvironment. |
68) interactions between glioma cells and the tumor-surrounding microenvironment will be |
69) e characterize that the von Hippel-Lindau tumor suppressor (pVHL), via its CRLpVHL, |
70) Here, we report that Leucine zipper tumor suppressor 2 (LZTS2) is downregulate |
71) hanced its phagocytic effect in vitro and tumor suppressor activity in vivo. |
72) t time our study demonstrates the in vivo tumor suppressor activity of RNF144A upon |
73) the JAK-STAT5 pathway and upregulation of tumor suppressor cytokine signaling 2 (SOC |
74) rematurely by oncogene hyperactivation or tumor suppressor dysfunction [oncogene-ind |
75) osis complex (TSC) results from loss of a tumor suppressor gene - TSC1 or TSC2, enco |
76) associated changes in target oncogene and tumor suppressor gene expression that migh |
77) The methylation status of five tumor suppressor genes and histone acetyla |
78) thylation induces epigenetic silencing of tumor suppressor genes in human lung cance |
79) ion of histones and in the methylation of tumor suppressor genes via oral rinse in p |
80) ersely regulating the target oncogenes or tumor suppressor genes. |
81) late and activate epigenetically silenced tumor suppressor genes. |
82) el identified miR-20a could function as a tumor suppressor in NSCLC through modulati |
83) e previously shown that StarD13 acts as a tumor suppressor in astrocytoma as well as |
84) miR-193a-3p acts as an oncogene or tumor suppressor in different cancers. |
85) monstrated that miR-30b-5p functions as a tumor suppressor in lung cancer, and re-se |
86) rationale to consider the status of this tumor suppressor in the clinical setting. |
87) presented suggest that StarD13 acts as a tumor suppressor inhibiting prostate cance |
88) binds to promyelocytic leukemia (PML), a tumor suppressor involved in non-canonical |
89) and somatic genetic variation to the p53 tumor suppressor pathway are known to prom |
90) cancer progression assigned RBM47 to be a tumor suppressor that acts by inhibiting E |
91) FBW7 is a tumor suppressor that functions as an Mcl- |
92) The transcription factor p53 is the major tumor suppressor that is often mutated in |
|